Literature DB >> 18239685

Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation.

Hidekatsu Iha1, Jean-Marie Peloponese, Lynn Verstrepen, Grzegorz Zapart, Fumiyo Ikeda, C Dahlem Smith, Matthew F Starost, Venkat Yedavalli, Karen Heyninck, Ivan Dikic, Rudi Beyaert, Kuan-Teh Jeang.   

Abstract

Nuclear factor kappa B (NF-kappaB) is a key mediator of inflammation. Unchecked NF-kappaB signalling can engender autoimmune pathologies and cancers. Here, we show that Tax1-binding protein 1 (TAX1BP1) is a negative regulator of TNF-alpha- and IL-1beta-induced NF-kappaB activation and that binding to mono- and polyubiquitin by a ubiquitin-binding Zn finger domain in TAX1BP1 is needed for TRAF6 association and NF-kappaB inhibition. Mice genetically knocked out for TAX1BP1 are born normal, but develop age-dependent inflammatory cardiac valvulitis, die prematurely, and are hypersensitive to low doses of TNF-alpha and IL-1beta. TAX1BP1-/- cells are more highly activated for NF-kappaB than control cells when stimulated with TNF-alpha or IL-1beta. Mechanistically, TAX1BP1 acts in NF-kappaB signalling as an essential adaptor between A20 and its targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239685      PMCID: PMC2262037          DOI: 10.1038/emboj.2008.5

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.

Authors:  M Yoshida
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium.

Authors:  S Roberts; S Kosanke; D Jankelow; C M Duran; M W Cunningham
Journal:  J Infect Dis       Date:  2000-12-20       Impact factor: 5.226

Review 4.  Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.

Authors:  Andy Wullaert; Karen Heyninck; Sophie Janssens; Rudi Beyaert
Journal:  Trends Immunol       Date:  2006-09-18       Impact factor: 16.687

5.  T6BP, a TRAF6-interacting protein involved in IL-1 signaling.

Authors:  L Ling; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 6.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.

Authors:  Masao Matsuoka; Kuan-Teh Jeang
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

7.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.

Authors:  M J May; F D'Acquisto; L A Madge; J Glöckner; J S Pober; S Ghosh
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.

Authors:  Andy Wullaert; Lynn Verstrepen; Sofie Van Huffel; Minou Adib-Conquy; Sigrid Cornelis; Marja Kreike; Mira Haegman; Karim El Bakkouri; Matthew Sanders; Kelly Verhelst; Isabelle Carpentier; Jean-Marc Cavaillon; Karen Heyninck; Rudi Beyaert
Journal:  J Biol Chem       Date:  2006-11-06       Impact factor: 5.157

9.  Human T-cell leukemia virus oncoprotein tax represses nuclear receptor-dependent transcription by targeting coactivator TAX1BP1.

Authors:  King-Tung Chin; Abel C S Chun; Yick-Pang Ching; Kuan-Teh Jeang; Dong-Yan Jin
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

10.  Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.

Authors:  Noula Shembade; Nicole S Harhaj; Daniel J Liebl; Edward W Harhaj
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

View more
  84 in total

1.  A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.

Authors:  Karine Enesa; Herwig P Moll; Le Luong; Christiane Ferran; Paul C Evans
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

Review 2.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

Review 3.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 4.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

5.  ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling.

Authors:  Linlin Gao; Helen Coope; Susan Grant; Averil Ma; Steven C Ley; Edward W Harhaj
Journal:  J Biol Chem       Date:  2011-09-01       Impact factor: 5.157

Review 6.  Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death.

Authors:  Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-16       Impact factor: 94.444

7.  IKKα takes control of canonical NF-κB activation.

Authors:  Christiane Pelzer; Margot Thome
Journal:  Nat Immunol       Date:  2011-08-18       Impact factor: 25.606

8.  Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.

Authors:  Fuminori Tokunaga; Hiroshi Nishimasu; Ryuichiro Ishitani; Eiji Goto; Takuya Noguchi; Kazuhiro Mio; Kiyoko Kamei; Averil Ma; Kazuhiro Iwai; Osamu Nureki
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

Review 9.  Ubiquitin-binding domains - from structures to functions.

Authors:  Ivan Dikic; Soichi Wakatsuki; Kylie J Walters
Journal:  Nat Rev Mol Cell Biol       Date:  2009-10       Impact factor: 94.444

10.  The four and a half LIM family members are novel interactants of the human T-cell leukemia virus type 1 Tax oncoprotein.

Authors:  Áine McCabe; Kenichi Hashimoto; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.